January, 2018 | ShangPharma Innovation

Endpoints: When VCs hand out mega-rounds to Vir and Gossamer, are they betting on the jockey or the horse?

January 24, 2018/in Media /by danderson

BioCentury: ShangPharma, Icahn in R&D Deal

January 19, 2018/in Media /by danderson

BioWorld: Other news to note

January 17, 2018/in Media /by danderson

Endpoints: AveXis wants $400M more for promising SMA gene therapy; ShangPharma partners with Icahn School of Medicine at Mount Sinai

January 16, 2018/in Media /by danderson

New York Business Journal: ShangPharma Innovation partners with Icahn School of Medicine

January 16, 2018/in Media /by danderson

BioSpace: ShangPharma Innovation and Icahn School of Medicine at Mount Sinai Forge Translational Research Collaboration

January 16, 2018/in Media /by danderson

ShangPharma Innovation and Icahn School of Medicine at Mount Sinai Forge Translational Research Collaboration

January 16, 2018/in Press Release /by danderson

ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit.